Plasana Medical Fundraising

THM Capital Advisory supports Plasana Medical in the finalization of its equity fund raising.
‍

Activity

Plasana Medical is developing Plasana One®, a medical device for the healing of chronic wounds (diabetic foot ulcers, venous leg ulcers, bedsores).

Based on a proprietary multi-jet cold plasma technology, Plasana One® accelerates healing by 30 to 50% while reducing the risk of infection, with a treatment advertised as faster (6 to 12 times), painless and compatible with home use.

Plasana Medical is a medtech from the Plasma Physics Laboratory (École Polytechnique & CNRS) and created by the TechnoFounders startup-studio.
‍

Objectives

Plasana Medical is raising €4 million in equity, supplemented by non-dilutive financing (grants and bank loans), to finance the ongoing PLASANA GENESIS clinical trial aimed at obtaining CE marking in 2026, prepare for marketing in Europe, and initiate the regulatory process in the United States.
‍

Investors

TF Participations (funds managed by TechnoFounders), family offices and business angels; non-dilutive financing in addition (grants and bank loans).